Prostate 'organoid' hints at how early BPA exposure may increase cancer risk

July 29, 2015, University of Illinois at Chicago
3D chemical structure of bisphenol A. Credit: Edgar181 via Wikimedia Commons

A first-of-its kind prostate 'organoid' grown from human embryonic stem cells has enabled researchers to show that exposure to bisphenol A, a chemical in many plastics, can cause overproduction of prostate stem cells in the developing organ—and thus may increase men's risk of prostate cancer.

The research, by andrologists at the University of Illinois at Chicago, is published online in the journal PLOS ONE.

About a millimeter in size, the organoid is coaxed into being from cultured human embryonic . Its 3-D structure resembles a prostate in miniature, and it has all the biomarkers found in the actual adult organ.

When researchers exposed the developing organoid to BPA, an additive used to soften plastic and found in everything from water bottles to carbonless receipts, the organoid grew an overabundance of prostate stem cells in 'nests' throughout the tissue.

"The higher number of stem cells we saw in developing organoids given very low doses of BPA may be the underlying mechanism by which BPA increases the risk for ," said Gail Prins, professor of physiology in the UIC College of Medicine and director of UIC's andrology laboratory, who led the study.

A normal prostate gland, Prins said, has just a few stem cells dispersed throughout, which give rise to new prostate tissue over the course of a man's life.

In any tissue or organ, an abnormally high number of stem cells could be a risk factor for developing cancer, Prins said. Stem cells divide infrequently, but they may last a lifetime, carrying forward any abnormalities to all the tissues they give rise to. In theory, the more stem cells an organ has, the greater the risk of mutations that could cause the tissue to turn cancerous.

In previous research, using either an animal model of prostate cancer or adult human prostate stem cells, Prins and colleagues showed that prostate stem cells exposed to BPA were more likely to give rise to tissues that showed signs of cancer. The new study confirms these findings in human tissue that is embryonic.

Using a cocktail of hormones and other factors associated with the developing embryonic prostate, Prins and co-author Esther Calderon-Gierszal, a UIC graduate student in urology, were able to coax human to differentiate into various mature cells and form a prostate organoid—a process known as directed differentiation. Other laboratories have used directed differentiation to create intestinal, thyroid and pancreas organoids.

The new findings support Prins' previous research. BPA is a known endocrine disrupter that mimics estrogen, she says, and the new study shows how that might be responsible for driving prostate cancer. If the developing prostate is exposed to BPA early in life, its stem cells may be more sensitive to the naturally rising levels of estrogen that men produce as they age.

"This is as definitive as it gets, when it comes to the effect of BPA on the developing prostate," she said. "It produces an abnormally high number of prostate stem cells in the tissue, and these nests are a strong candidate for why exposure to BPA during development has been linked to prostate cancer later in life."

Explore further: Exposure to BPA in developing prostate increases risk of later cancer

Related Stories

Exposure to BPA in developing prostate increases risk of later cancer

June 17, 2013
Early exposure to BPA (bisphenol A) – an additive commonly found in plastic water bottles and soup can liners – causes an increased cancer risk in an animal model of human prostate cancer, according to University of Illinois ...

BPA increases risk of cancer in human prostate tissue

January 7, 2014
Fetal exposure to a commonly used plasticizer found in products such as water bottles, soup can liners and paper receipts, can increase the risk for prostate cancer later in life, according to a study from the University ...

BPA exposure during fetal development raises risk of precancerous prostate lesions

June 23, 2014
A new study has found for the first time that the endocrine-disrupting chemical bisphenol A (BPA) reprograms the developing prostate, making the gland more susceptible to precancerous lesions and other diseases later in a ...

Exposure to low doses of BPA linked to increased risk of prostate cancer in human stem cells

June 17, 2013
Exposing developing tissue to low levels of the plastic bisphenol A, commonly known as BPA, is linked to a greater incidence of prostate cancer in tissue grown from human prostate stem cells, a new study finds. The results ...

Scientists discover why some prostate tumours are resistant to radiotherapy

July 24, 2015
Scientists at the University of York believe they have identified how some tiny regulatory molecules in cells can make prostate cancers resistant to radiotherapy.

The newest precision medicine tool: Prostate cancer organoids

September 4, 2014
Research led by investigators at Memorial Sloan Kettering Cancer Center has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory, giving researchers an exciting ...

Recommended for you

Some brain tumors may respond to immunotherapy, new study suggests

December 10, 2018
Immunotherapy has proved effective in treating a number of cancers, but brain tumors have remained stubbornly resistant. Now, a new study suggests that a slow-growing brain tumor arising in patients affected by neurofibromatosis ...

Study finds higher risk of breast cancer for women after giving birth

December 10, 2018
Younger women who have recently had a child may have a higher risk of breast cancer than their peers of the same age who do not have children, according to a large-scale analysis co-led by a University of North Carolina Lineberger ...

A code for reprogramming immune sentinels

December 10, 2018
For the first time, a research team at Lund University in Sweden has successfully reprogrammed mouse and human skin cells into immune cells called dendritic cells. The process is quick and effective, representing a pioneering ...

Researchers develop personalized medicine tool for inherited colorectal cancer syndrome

December 10, 2018
An international team of researchers led by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has developed, calibrated, and validated a novel tool for identifying the genetic changes in Lynch syndrome genes ...

Study shows key enzyme linked to therapy resistance in deadly lung cancer

December 10, 2018
Researchers at The University of Texas MD Anderson Cancer Center have identified a link between an enzyme tied to cancer formation and therapy resistance in patients with epidermal growth factor receptor (EGFR)-mutant non-small ...

Potential seen for tailoring treatment for acute myeloid leukemia

December 8, 2018
Advances in rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia (AML).


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.